Aap Implantate AG Begins 2026 with Positive Revenue Growth

aap Implantate AG reports stable growth in Q1 2026, slightly surpassing last year's revenue. The USA drives significant growth, showing an 11% increase in EUR and 23% in local currency despite delays in instrument deliveries. This confirms strong growth potential in this crucial market.

Europe, particularly Germany and Spain, shows solid performance with increases of 15% and 19% respectively. However, geopolitical factors caused temporary slowdowns in the Middle East. The Latin American region remains steady, with growth contributions from Peru and Puerto Rico.

The Asia-Pacific region marks a notable 50% revenue increase due to demand in China, Taiwan, and Korea, though facing some volatility. aap also achieved full MDR certification for its LOQTEQ® products, securing sales in CE markets through 2027. These developments bolster the company's strategic position despite ongoing global uncertainties.